MedPath

Hospital General de México "Dr. Eduardo Liceaga"

🇲🇽Mexico
Ownership
-
Employees
-
Market Cap
-
Website

Serum Insulin Response After Acute and Chronic Sucralose Ingestion in Healthy Volunteers With Variable Body Mass Index

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: sucralose 48 mg (splenda)/day for ten weeks
First Posted Date
2018-10-11
Last Posted Date
2018-10-11
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
95
Registration Number
NCT03703141

Structured Exercise Prescription Program in Obese Children

Not Applicable
Conditions
Childhood Obesity
Liver Diseases
Exercise
Cardiovascular Risk Factor
Metabolic Syndrome
Obesity
Interventions
Other: Personalized structured exercise program
Other: Non personalized non-structured exercise program
First Posted Date
2018-06-11
Last Posted Date
2018-06-11
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
140
Registration Number
NCT03552367
Locations
🇲🇽

Hospital General de Mexico Eduardo Liceaga, Mexico City, Del. Cuauhtemoc, Mexico

Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive Patients

Phase 2
Conditions
Type 2 Diabetes Mellitus
Hypertension
Obesity
Interventions
First Posted Date
2014-09-10
Last Posted Date
2015-03-30
Lead Sponsor
Hospital General de México Dr. Eduardo Liceaga
Target Recruit Count
300
Registration Number
NCT02235519
Locations
🇲🇽

Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico, Mexico, D.F., Mexico

© Copyright 2025. All Rights Reserved by MedPath